
It is a type of cancer known as invasive ductal carcinoma that develops when aberrant cells that are growing in the milk duct lining transform and spread to the breast tissue outside the duct walls.
Timely treatment of Invasive Ductal Carcinoma is vital for many possible reasons:
Possible signs of invasive ductal carcinoma
The exact causes of IDC are not fully recognised, but several factors are involved in its development:
Risk Factors
India is making significant strides in the treatment of Invasive Ductal Carcinoma (IDC) with the latest Technologies like Hormone or HER2-targeted therapies that target particular molecular traits of IDC, such as hormone receptor-positive and HER2-positive tumours, which are the main focus of research. Recurrence risk reduction and better patient outcomes are the goals of these treatments, including CDK4/6 inhibitors.
Adopting good lifestyle practices and taking charge of your health is key to preventing invasive ductal carcinoma (IDC); here are some tips-
Lumpectomy: It is the removal of a small margin of the surrounding tissue of the breast. It is also known as breast-conserving surgery. A lumpectomy may be followed by radiation treatments to treat any residual cancer cells.
Mastectomy: It is the removal of the entire breast. Mastectomy is a treatment for patients with multiple, very aggressive, or large invasive ductal tumours in most advanced cases.
Cost Start From USD 3000 - USD 4000Explore Options
Radiation Therapy: Treatments using high-energy rays to target cancer cells and reduce tumour size are known as radiation therapy.
Chemotherapy : Chemotherapy for breast cancer uses high-dose medications to kill cancer cells. You may receive chemo through veins or as a pill. Chemotherapy makes cancer cells smaller so that surgery can remove them more easily. It can be your primary treatment if you have stage 4 (metastatic) invasive ductal carcinoma.
Cost Start From USD 600 - USD 700Explore Options
Immunotherapy : Healthcare Providers may combine immunotherapy and chemotherapy to shrink the size of tumors before surgery. It also boosts your immune system to discover and destroy dangerous cancer cells.
Cost Start From USD 3000 - USD 5000Explore Options
Targeted Therapy : Treatments targeting genetic changes or malignant cells may be combined with immunotherapy and chemotherapy.
Cost Start From USD 8000 - USD 12000Explore Options
HormonalTherapy : Hormones are often necessary for cancer cells to proliferate and develop. Hormone treatment breaks that connection.
Cost Start From USD 3500 - USD 5500Explore Options
Clinical Evaluation
Imaging Studies
Biopsy
Laboratory Tests
MediRehab (chain of Rehab centres - Part of MediGence) provides comprehensive rehabilitation services to support invasive ductal carcinoma (IDC) patients in India. These services include:
MediGence can assist and guide you in selecting the best physician and medical facility for your care.
Depending on the circumstances, your doctor might recommend medication to help manage your symptoms and complement the course of treatment.









Chennai, India
Sri Ramachandra Medical Centre located in Chennai, India is accredited by ISO, JCI, NABH, NABL. Also listed below are some of the most prominent infrastructural details:

Mumbai, India
Seven Hills Hospital located in Mumbai, India is accredited by JCI, NABH, NABL. Also listed below are some of the most prominent infrastructural details:

Delhi, India
Opinion & Option
We submit the most accurate opinion and options from one or more countries for your review
Consult Privately
Consult with a certified specialist privately on our telemedicine platform even before you decide to travel
Logistics
We handle flights, visas, transfers, and accommodation—so you can focus on your health.
Recovery
Our In-house rehabilitation service packages to better your recovery and treatment outcome
It is a kind of breast cancer called invasive ductal carcinoma (IDC) that begins in the milk ducts and spreads to the surrounding breast tissue. A non-invasive disorder known as ductal carcinoma in situ (DCIS) occurs when abnormal cells remain inside the milk ducts and have not migrated to neighbouring tissues.
Invasive ductal carcinoma can affect anyone, but it is more commonly diagnosed in post-menopausal women over the age of 50.
About 83% of all occurrences of breast cancer are invasive ductal carcinoma, making it the most prevalent kind.
The lymphatic system, which includes the lymph nodes under the arms, is a potential route of spread for invasive ductal carcinoma. Additionally, it can travel through blood arteries to the liver, lungs, or bones, among other body regions.
Although the treatments are successful in combating invasive ductal carcinoma, they may also result in adverse effects like changes in appetite, nausea, exhaustion, and hair loss.
The length of recovery following therapy for invasive ductal carcinoma varies based on the cancer's type and stage as well as the patient's general health.
It is possible to treat invasive ductal carcinoma, mainly if diagnosed early. The prognosis for invasive ductal carcinoma has dramatically improved over time due to developments in medical technology and available treatments.
The stage of the malignancy, general health, and response to treatment are some factors affecting the survival rate for invasive ductal carcinoma. The likelihood of a successful outcome increases with the timing of cancer diagnosis and treatment.
It is thought that invasive (infiltrating) ductal carcinoma is one of the most aggressive types of breast cancer. If not identified and treated right away, this kind of cancer has the potential to spread swiftly to other body parts.
A form of invasive ductal carcinoma known as triple-negative IDC is devoid of human epidermal growth factor receptor 2 (HER2), progesterone receptors (PR), and estrogen receptors (ER). When compared to other subtypes of breast cancer, this one is frequently more aggressive and challenging to treat. Targeted therapy is making advancements in this field.
Yes, irreparable harm may result from invasive ductal carcinoma (IDC), particularly if the malignancy is not identified and treated correctly. IDC has the potential to spread to distant organs and lymph nodes, causing more serious and reversible harm. Early detection and timely treatment are essential to avoid irreparable harm and increase the likelihood of positive results.
Most hospitals in India offer the following:
One can go home in 1-2 days after the surgery, and it takes 4-6 weeks to recover and get back to normal activities fully.